Global Medicare · Science
Understanding fertility through clinical science and structured research.
Explore the scientific context behind Global Medicare’s ovarian and endometrial programs, autologous preparations and observational research at IVF Baden-Baden.
Scientific areas
Three areas. One connected scientific framework.
Global Medicare separates patient-facing programs, scientific background and specific observational research so that each layer can be understood in its proper context.
Ovarian Science
Scientific context related to ovarian reserve, ovarian response, reproductive age and the ovarian research framework.
Endometrial Science
Scientific context related to endometrial development, endometrial factors and implantation-associated clinical questions.
Autologous Preparations
Understand the distinction between Standard-PRP and IAS within the current clinical and research framework.
Ovarian Science
Understanding ovarian reserve and ovarian response.
Ovarian-factor fertility assessment can involve the patient’s reproductive history, ovarian reserve, ovarian response during previous stimulation and the broader clinical context.
Global Medicare does not interpret individual AMH, AFC or other medical results online. These findings require specialist clinical interpretation.
Endometrial Science
Understanding endometrial development and clinical context.
Endometrial assessment can involve multiple clinical factors, including endometrial development, previous implantation history and specific endometrial conditions.
Within 03-REGEN-AR, the principal comparison focuses on endometrial development, particularly endometrial thickness, alongside additional clinical parameters.
Autologous preparations
Standard-PRP and IAS within the research framework.
Both Standard-PRP and IAS are autologous preparations. IAS includes an additional processing step.
The clinical choice between these approaches is made independently from research participation. Neither approach should be presented as superior on the basis of the observational studies alone.
Derived from the patient’s own biological material.
Processing depends on the selected clinical approach.
Two distinct autologous preparation approaches.
Outcomes are documented within observational research.
IAS should not be described as purified exosome therapy. Treatment selection remains a clinical decision.
Clinical care & research
Treatment decisions and research participation remain separate.
The decision regarding clinical care is made independently of whether a patient participates in observational research.
Global Medicare provides information and coordination. Final clinical decisions and research eligibility remain with the authorised medical and research teams.
Research Programs
Two observational programs at IVF Baden-Baden.
The ovarian and endometrial programs are documented separately, with their own populations, objectives and clinical parameters.
ExoRegenOvo
Study 02-REGEN-AR · ovarian observational research.
RegenEndo
Study 03-REGEN-AR · endometrial observational research.
Scientific principles
Clear boundaries are part of good science.
Scientific communication should explain what is known, what is being observed and what still requires clinical or research assessment.
Research participation does not guarantee an individual health or pregnancy benefit.
Individual findings require interpretation by the authorised medical team.
Treatment decisions remain independent from research participation.
Eligibility can only be determined by the authorised research team.
Explore further
Science becomes useful when it helps clarify the next question.
Explore the specific ovarian and endometrial scientific areas, learn about the observational research programs or begin with the patient pathway that best matches your situation.